China’s cancer breakthrough on CAR-T cell therapy shows progress
In June, Chinese regulators approved the world’s first CAR-T cell therapy for solid tumour cancers, developed by a drug company based in Shanghai.
One month later, at a hospital in the city, a New Zealander with advanced cancer of the stomach and small intestine became the first international patien
此摘要由5News从媒体的公开信息源汇聚而成。 包含完整背景的全文在www.scmp.com — 内容归South China Morning Post - China所有。
